As interest in injectable biologics for cancer and other diseases continues to surge, CDMO Simtra BioPharma Solutions is catching the wave stateside with plans for a new commercial manufacturing ...
CHASKA, Minn., June 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (LFCR) (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today ...
COLLEGE STATION, Texas, Sept. 15, 2025 /PRNewswire/ -- Matica Biotechnology, Inc. (Matica Bio), a leading contract development and manufacturing organization (CDMO) specializing in viral vector ...
Hosted on MSN
Regenxbio signals RGX-202 pivotal enrollment surpasses 50% as company initiates commercial manufacturing in Q3 2025
Curran Simpson, President and CEO, highlighted strong late-stage clinical progress and the company's positioning for multiple gene therapy launches, stating the business is “in-store for an exciting ...
Greenwich LifeSciences updates on commercial manufacturing of GP2 and prepares for BLA filing for GLSI-100 in breast cancer treatment. Greenwich LifeSciences, Inc. announced progress in the commercial ...
It’s no secret manufacturers are beginning to realize the untapped benefits of Industry 4.0 and industrial Internet of Things (IIoT) smart technologies to digitally transform their factories and make ...
OXB, a U.K.-based cell and gene therapy manufacturer, expanded its ongoing partnership with Bristol Myers Squibb to supply lentiviral vectors for the pharma giant’s CAR-T programs. The newly expanded ...
The integration of commercial and military manufacturing (ICMM) has been a subject of extensive debate and steadily increasing policy implementation in recent years. This integration can be defined as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results